Frequently Asked Questions
The Minimally Invasive Gastrointestinal Surgical Systems Market size will be worth USD 16,395.04 million by 2028.
The Minimally Invasive Gastrointestinal Surgical Systems Market growth rate will be 8.06% by 2028.
The rise in the growth of the minimally-invasive surgery devices, increase in the healthcare expenditure and increase in the healthcare outcomes are the growth drivers of the Minimally Invasive Gastrointestinal Surgical Systems Market.
The product type, surgery and end-user are the factors on which the Minimally Invasive Gastrointestinal Surgical Systems Market research is based.
The major companies in the Minimally Invasive Gastrointestinal Surgical Systems Market are Medtronic, Medical Devices Business Services, Inc., Stryker, Smith & Nephew, Abbott, Applied Biomedical, LLC, California Resources Corporation, Microline Surgical, Zimmer Biomet, B. Braun Melsungen AG, CONMED Corporation, HOYA Corporation, Applied Medical Resources Corporation, Aesculap, Inc., Johnson & Johnson Services, Inc., Karl Storz Gmbh & Co. Kg, Novatract Surgical Inc., REMA Medizintechnik GmbH, Teleflex Incorporated, Boston Scientific Corporation and Given Imagin Ltd.
